pamidronate has been researched along with Rheumatism in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate, along with other bisphosphonates, has been used for treatment of bone pain secondary to malignant involvement or metastatic disease for years." | 4.85 | Pamidronate treatment in rheumatology practice: a comprehensive review. ( Boulman, N; Feld, J; Odeh, M; Rimar, D; Rosner, I; Rozenbaum, M; Slobodin, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slobodin, G | 1 |
| Rosner, I | 1 |
| Feld, J | 1 |
| Rimar, D | 1 |
| Rozenbaum, M | 1 |
| Boulman, N | 1 |
| Odeh, M | 1 |
| Acott, PD | 1 |
| Wong, JA | 1 |
| Crocker, JF | 1 |
| Lang, B | 1 |
| O'Regan, P | 1 |
| Renton, KW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combined Treatment With TNF (Tumor Necrosis Factor) Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression[NCT02313727] | Phase 4 | 30 participants (Anticipated) | Interventional | 2014-12-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pamidronate and Rheumatism
| Article | Year |
|---|---|
Pamidronate treatment in rheumatology practice: a comprehensive review.
Topics: Anti-Inflammatory Agents; Diphosphonates; Humans; Pain; Pamidronate; PubMed; Randomized Controlled T | 2009 |
1 trial available for pamidronate and Rheumatism
| Article | Year |
|---|---|
Pamidronate distribution in pediatric renal and rheumatologic patients.
Topics: Adolescent; Alkaline Phosphatase; Area Under Curve; Bone and Bones; Bone Density Conservation Agents | 2006 |